YTEN solid DD $YTEN w/ +ve FDA CRSPR-AG announcement end of last week, potential headwinds now become tailwinds; only $19m m/cap w/ $14.5m cash /$MON JV and many new traits avail to partner, this co (and ag-editing) has potential to be one of best sector stories of the year.
Reminder, tiny debt, solid balance sheet, strong cash on hand and many Catalysts ahead.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.